Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|February 17, 2023
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activityBhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Leukemia|May 26, 2018
Consequences of mutant TET2 on clonality and subclonal hierarchyCassandra M Hirsch, Aziz Nazha, Kassy Kneen, et al.
American Journal of Hematology|January 12, 2017
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agentsElias Jabbour, Paolo Strati, Monica Cabrero, et al.
Blood Advances|February 3, 2019
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasiaHassan Awada, Yasunobu Nagata, Abhinav Goyal, et al.
Blood Advances|March 24, 2019
NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapyGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.
Nature|August 17, 2012
Passenger deletions generate therapeutic vulnerabilities in cancerFlorian L Muller, Simona Colla, Elisa Aquilanti, et al.
Blood Advances|November 12, 2021
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromesCarmelo Gurnari, Simona Pagliuca, Yihong Guan, et al.
Cancer Discovery|July 4, 2012
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastomaGiannicola Genovese, Ayla Ergun, Sachet A Shukla, et al.
Pageof 10